Grants from Food and Drug Administration

528 opportunities — 8 currently open. Filter open grants →

Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed

Archived
Closes: Apr 1, 2024

Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed

Archived
Closes: Apr 1, 2024

Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional

Archived
Closes: Apr 5, 2024

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Archived
Closes: Mar 21, 2024

Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

Archived
Closes: Apr 8, 2024

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Archived
Closes: Apr 8, 2024

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Archived
Closes: Apr 8, 2024

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Archived
Closes: Apr 8, 2024

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Archived
Closes: Apr 8, 2024

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Archived
Closes: Apr 8, 2024

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Archived
Closes: Apr 8, 2024

Critical Path Public Private Partnerships Clinical Trials Optional

Archived
Closes: Mar 4, 2024

Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional

Archived
Closes: Apr 2, 2024

National Project to Support and Promote Consistent Implementation of the Regulatory Standards for the Growing, Harvesting, Packing and Holding of Produce for Human Consumption and Produce Regulatory Standards (PRPS) (U2F) -Cooperative Agreements

Archived
Closes: Jun 10, 2024

Produce Safety Alliance-U01 Clinical Trials Not Allowed

Archived
Closes: Feb 29, 2024

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Archived
Closes: Mar 11, 2024

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Archived
Closes: Feb 29, 2024

Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed

Archived
Closes: Feb 27, 2024

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Here and Clinical Trial Designator - Clinical Trials Not Allowed

Archived
Closes: Feb 27, 2024

Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed

Archived
Closes: Mar 29, 2024